Path Fertility Releases its Company Facts Sheet

SALT LAKE CITY, UT / ACCESS Newswire / March 10, 2026 / Path FertilityTM, an epigenetics-driven fertility technology ...
Business Wire

Meitheal Pharmaceuticals Secures Exclusive Commercial Licensing Agreement for Three Biosimilars in the U.S.

CHICAGO--(BUSINESS WIRE)--Meitheal Pharmaceuticals, Inc. (“Meitheal”), a fully integrated biopharmaceutical company based in Chicago and focused on the development and commercialization of generic ...

Path Fertility: For Couples in "Fertility Limbo," a Real-World Study Published by JARG Finds "Normal" Semen Analysis May Not Tell the Whole Story

A peer-reviewed, multi-clinic study published in the Journal of Assisted Reproduction and Genetics suggests an epigenetic sperm-quality profile can add missing information for infertile couples and cl ...
The Healthy @Reader's Digest on MSN

16,500 critical fertility drugs recalled nationwide

Fortunately, a fix should be relatively simple for most.
Benzinga.com

Celmatix Nominates First Lead Compound in Oral Fertility Drug Program

Dr. Piraye Yurttas Beim, Founder and CEO of Celmatix, stated, "Our oral FSH program stands to fundamentally change the landscape of fertility treatments. By offering a non-invasive alternative to ...